Health TrialsbyHealthPanel

Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases

ConditionsNeuro-co-cardiological DiseasesPost-cardiac Surgery Cerebrovascular DiseasesVascular Lesion
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBeijing Anzhen Hospital

About this trial

The objective of this observational cohort study is to evaluate the clinical outcomes of various treatment strategies for cerebrovascular and cardiovascular diseases. Furthermore, it aims to investigate the factors that influence adverse outcomes from these treatments.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years;

Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases.

Disqualifiers

The expected survival is less than 1 years;

Simultaneously merge other serious diseases;

Trial population

Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • Interventional or surgical treatment

    Procedure/Surgery

    Simultaneous interventional or surgical treatment/staged interventional or surgical treatment

  • Interventional or surgical treatment

    Procedure/Surgery

    Interventional or surgical treatment

Treatment groups

2,000 Participants
are divided into 5 treatment groups
Group A: Neuro-co-cardiological diseases: Simultaneous treatment1 intervention
Group B: Neuro-co-cardiological diseases: Staged treatment1 intervention
Group C: Neuro-co-cardiological diseases: Conservative treatment0 interventions
Group D: Post-cardiac surgery Cerebrovascular disease: Surgery/Interventional Treatment1 intervention
Group E: Post-cardiac surgery Cerebrovascular disease: Conservative treatment0 interventions

Trial outcomes

Primary outcomes

1

Modified Rankin Scale Score

Modified Rankin Scale（0-6）, A lower MRS score indicates better functional status for the patient.

Time frame
90±7 days

Secondary outcomes

1

Modified Rankin Scale Score

Modified Rankin Scale（0-6）, A lower MRS score indicates better functional status for the patient.

Time frame
7±1 days or the day discharged
2

Modified Rankin Scale Score

Modified Rankin Scale（0-6）, A lower MRS score indicates better functional status for the patient.

Time frame
365±30 days
3

Perioperative complication rate

Time frame
30±7 days
4

Rate of cardiovascular and cerebrovascular events

Time frame
90±7 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Beijing Anzhen Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now